1. |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424.
|
2. |
Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med, 2011, 365(5): 395-409.
|
3. |
Meza R, Jeon J, Toumazis I, et al. Evaluation of the benefits and harms of lung cancer screening with low-dose computed tomography: modeling study for the US preventive services task force. JAMA, 2021, 325(10): 988-997.
|
4. |
Isbell JM, Deppen S, Putnam JB Jr, et al. Existing general population models inaccurately predict lung cancer risk in patients referred for surgical evaluation. Ann Thorac Surg, 2011, 91(1): 227-233.
|
5. |
罗汶鑫, 李为民. 肺癌的表观遗传学研究进展及其临床意义. 中国呼吸与危重监护杂志, 2018, 17(3): 313-318.
|
6. |
Kerr KM, Galler JS, Hagen JA, et al. The role of DNA methylation in the development and progression of lung adenocarcinoma. Dis Markers, 2007, 23(1-2): 5-30.
|
7. |
Cheng L, Luo S, Jin C, et al. FUT family mediates the multidrug resistance of human hepatocellular carcinoma via the PI3K/Akt signaling pathway. Cell Death Dis, 2013, 4(11): e923.
|
8. |
Liu YC, Yen HY, Chen CY, et al. Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells. Proc Natl Acad Sci U S A, 2011, 108(28): 11332-11337.
|
9. |
Yu M, Cui XY, Wang H, et al. FUT8 drives the proliferation and invasion of trophoblastic cells via IGF-1/IGF-1R signaling pathway. Placenta, 2019, 75: 45-53.
|
10. |
Wu ZL, Whittaker M, Ertelt JM, et al. Detecting substrate glycans of fucosyltransferases with fluorophore-conjugated fucose and methods for glycan electrophoresis. Glycobiology, 2020, 30(12): 970-980.
|
11. |
Fang YF, Qu YH, Ji LT, et al. Novel blood-based FUT7 DNA methylation is associated with lung cancer: especially for lung squamous cell carcinoma. Clin Epigenetics, 2022, 14(1): 167.
|
12. |
Qiao R, Di FF, Wang J, et al. Identification of FUT7 hypomethylation as the blood biomarker in the prediction of early-stage lung cancer. J Genet Genomics, 2023, 50(8): 573-581.
|
13. |
Chen PX, Liu YH, Wen YK, et al. Non-small cell lung cancer in China. Cancer Commun (Lond), 2022, 42(10): 937-970.
|
14. |
De Koning HJ, Van Der Aalst CM, De Jong PA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med, 2020, 382(6): 503-513.
|
15. |
Church TR, Black WC, Aberle DR, et al. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med, 2013, 368(21): 1980-1991.
|
16. |
Zhao H, Marshall HM, Yang IA, et al. Screen-detected subsolid pulmonary nodules: long-term follow-up and application of the PanCan lung cancer risk prediction model. Br J Radiol, 2016, 89(1060): 20160016.
|
17. |
Kodama K, Higashiyama M, Takami K, et al. Treatment strategy for patients with small peripheral lung lesion(s): intermediate-term results of prospective study. Eur J Cardiothorac Surg, 2008, 34(5): 1068-1074.
|
18. |
Yotsukura M, Asamura H, Motoi N, et al. Long-term prognosis of patients with resected adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung. J Thorac Oncol, 2021, 16(8): 1312-1320.
|
19. |
Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization Classification of Lung Tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol, 2015, 10(9): 1243-1260.
|
20. |
Macmahon H, Naidich DP, Goo JM, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology, 2017, 284(1): 228-243.
|
21. |
Tanner NT, Aggarwal J, Gould MK, et al. Management of pulmonary nodules by community pulmonologists: a multicenter observational study. Chest, 2015, 148(6): 1405-1414.
|
22. |
Tanner NT, Porter A, Gould MK, et al. Physician assessment of pretest probability of malignancy and adherence with guidelines for pulmonary nodule evaluation. Chest, 2017, 152(2): 263-270.
|
23. |
Mazzone PJ, Silvestri GA, Souter LH, et al. Screening for lung cancer: CHEST Guideline and Expert Panel Report. Chest, 2021, 160(5): e427-e494.
|
24. |
Swensen SJ, Silverstein MD, Ilstrup DM, et al. The probability of malignancy in solitary pulmonary nodules: application to small radiologically indeterminate nodules. Arch Intern Med, 1997, 157(8): 849-855.
|
25. |
Mcwilliams A, Tammemagi MC, Mayo JR, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med, 2013, 369(10): 910-919.
|
26. |
Gould MK, Ananth L, Barnett PG. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules. Chest, 2007, 131(2): 383-388.
|
27. |
Herder GJ, Van Tinteren H, Golding RP, et al. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Chest, 2005, 128(4): 2490-2496.
|
28. |
贾国华, 周水梅, 王静. 肿瘤标志物联合肺癌概率模型在肺部结节鉴别诊断中的价值. 中国呼吸与危重监护杂志, 2017, 16(4): 337-340.
|
29. |
Pink M, Ratsch BA, Mardahl M, et al. Imprinting of skin/inflammation homing in CD4+ T cells is controlled by DNA methylation within the fucosyltransferase 7 gene. J Immunol, 2016, 197(8): 3406-3414.
|
30. |
Miyoshi E, Moriwaki K, Nakagawa T. Biological function of fucosylation in cancer biology. J Biochem, 2008, 143(6): 725-729.
|
31. |
Du T, Jia XY, Dong XC, et al. Cosmc disruption-mediated aberrant O-glycosylation suppresses breast cancer cell growth via impairment of CD44. Cancer Manag Res, 2020, 12: 511-522.
|
32. |
Zeng Q, Vogtmann E, Jia MM, et al. Tobacco smoking and trends in histological subtypes of female lung cancer at the Cancer Hospital of the Chinese Academy of Medical Sciences over 13 years. Thorac Cancer, 2019, 10(8): 1717-1724.
|
33. |
Furuya K, Murayama S, Soeda H, et al. New classification of small pulmonary nodules by margin characteristics on high-resolution CT. Acta Radiol, 1999, 40(5): 496-504.
|
34. |
Xu DM, Van Der Zaag-Loonen HJ, Oudkerk M, et al. Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up. Radiology, 2009, 250(1): 264-272.
|
35. |
Jin CH, Cao JL, Cai Y, et al. A nomogram for predicting the risk of invasive pulmonary adenocarcinoma for patients with solitary peripheral subsolid nodules. J Thorac Cardiovasc Surg, 2017, 153(2): 462-469 e1. doi:.
|
36. |
Van Riel SJ, Sánchez CI, Bankier AA, et al. Observer variability for classification of pulmonary nodules on low-dose CT images and its effect on nodule management. Radiology, 2015, 277(3): 863-871.
|
37. |
Kazerooni EA, Armstrong MR, Amorosa JK, et al. ACR CT accreditation program and the lung cancer screening program designation. J Am Coll Radiol, 2015, 12(1): 38-42.
|
38. |
Seemann MD, Staebler A, Beinert T, et al. Usefulness of morphological characteristics for the differentiation of benign from malignant solitary pulmonary lesions using HRCT. Eur Radiol, 1999, 9(3): 409-417.
|